Sughrue Mion, PLLC
Anti-DLL3 antibody
It is intended to disclose an antibody which binds to DLL3 protein. Preferably, the antibody of the present invention recognizes a region from amino acids 216 to 492 in human DLL3 having the amino acid sequence as set forth in SEQ ID NO: 1. The present invention also provides a pharmaceutical composition, for example, an anticancer agent, comprising the antibody of the present invention as an active ingredient. The present invention further discloses a method for diagnosing cancer using the antibody of the present invention and a diagnostic drug for cancer comprising the antibody of the present invention.
THE UNIVERSITY OF TOKYO CHUGAI SEIYAKU KABUSHIKI KAISHA
C C C A C C A C A C C G G C
C07K C07K C07K A61K C12Q C07K A61K C12Q A61P C07K C07K G01N G01N C07K
additional additional additional additional inventional additional inventional additional inventional inventional inventional inventional additional additional
Kenji Hiroyuki Shumpei
Yoshida Aburatani Ishikawa